Skip to content
★ Sign in to follow
KB

Kevin Bruce Yankton

Directeur Comptable
Total declarations
35
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€107k

Latest filing published 19 May 2023 for Twist Bioscience Corp, €838.

Insider track record

Disclosed buys
0
Disclosed sells
5

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Kevin Bruce Yankton: trading record in brief

Kevin Bruce Yankton, listed as senior executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Twist Bioscience Corp and Varex Imaging Corp. In total, 35 filings cover trades dated from 15 February 2018 to 17 May 2023.

The open-market record consists of 5 sales worth €107k, with no purchase. Besides market trades, the filings include 22 share grants and 8 option exercises.

The newest entry dates from 19 May 2023: a share grant of €838, in Twist Bioscience Corp. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Kevin Bruce Yankton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations16 total

16 of 16 declarations